Evidence map›Paper›PMID 34233845›Full record

ArticleJournal of hepatology2021

Androgen receptor, neovascularization and liver cancer metastasis.

Morgan W Feng, Kaisa L Hanley, Gen-Sheng Feng

Abstract readEditorialComment
In one paragraph

Article in Journal of hepatology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Morgan W FengDepartment of Pathology, Division of Biological Sciences, University of California at San Diego, La Jolla, CA 92093-0864, USA.
Kaisa L HanleyDepartment of Pathology, Division of Biological Sciences, University of California at San Diego, La Jolla, CA 92093-0864, USA.
Gen-Sheng FengDepartment of Pathology, Division of Biological Sciences, University of California at San Diego, La Jolla, CA 92093-0864, USA. Electronic address: gfeng@ucsd.edu.

Funding

Project 4: Interrogating and harnessing age-related IFN signaling and innate immunity in HCC prevention and therapyP01AG073084 · NIA · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI PETER D. ADAMS, GERALD SHADEL · 2021 to 2026
$13.6M
Tumor-promoting liver injuries and mechanismsR01CA239629 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FENG, GEN-SHENG · 2020 to 2024
$2.5M
Intra- and inter-cellular signals that drive hepato-oncogenesisR01CA236074 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FENG, GEN-SHENG · 2020 to 2024
$2.1M
A new mechanism of hepatocyte proliferation under stressR01DK128320 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FENG, GEN-SHENG · 2021 to 2024
$1.9M
NCI NIH HHS R01 CA236074NCI NIH HHS R01 CA239629NIA NIH HHS P01 AG073084NIDDK NIH HHS R01 DK128320
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Liver NeoplasmsReceptors, AndrogenHumansNeovascularization, PathologicReceptors, Androgen

Identifiers

PMID34233845
PMCPMC9948677

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.